Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

(MedPage Today) — SAN FRANCISCO — Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
Median PFS improved from 10.7…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogu/120094

Author :

Publish date : 2026-02-28 15:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

People Are Chilling Their Carbs to Try to Lose Weight

Living After Suicidality: A Physician’s Framework for Healing

Related Posts

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

‘I’m not being listened to’ – new health plan launched as women say they are still ignored

Brokers Get Paid More to Enroll Seniors in Medicare Advantage. Is That a Problem?

Surgeon Accused of Removing Wrong Organ Faces Manslaughter Charge

FDA Approves Sparsentan as First FSGS Treatment

A Simple Test Could Predict a Patient’s Final 24 Hours

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

‘I’m not being listened to’ – new health plan launched as women say they are still ignored

Brokers Get Paid More to Enroll Seniors in Medicare Advantage. Is That a Problem?

Surgeon Accused of Removing Wrong Organ Faces Manslaughter Charge

FDA Approves Sparsentan as First FSGS Treatment

A Simple Test Could Predict a Patient’s Final 24 Hours

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Is a super El Niño imminent, and what could the impacts be?

Categories

Archives